Two Sigma Securities’s Cocrystal Pharma COCP Stock Holding History

Two Sigma Securities’s Portfolio COCP Stock Details COCP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.4K	Buy	15,255 +2,503	+20%	+$2.58K	﹤0.01%	1411
2025 Q4	$12.5K	Buy	+12,752	New	+$13.5K	﹤0.01%	1262
2022 Q4	–	Sell	-1,668	Closed	-$6K	–	2671
2022 Q3	$6K	Buy	1,668 +604	+57%	+$2.83K	﹤0.01%	2462
2022 Q2	$5K	Buy	+1,064	New	+$5.67K	﹤0.01%	2109
2022 Q1	–	Sell	-3,306	Closed	-$26K	–	2160
2021 Q4	$26K	Buy	3,306 +1,808	+121%	+$18.5K	﹤0.01%	1380
2021 Q3	$19K	Buy	+1,498	New	+$19.8K	﹤0.01%	1464

Other funds holding COCP

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T3 Companies New York $76.8M AUM

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Two Sigma Securities's COCP Position: Q1 2026 in Review

Two Sigma Securities increased its Cocrystal Pharma (COCP) stake by 20% in Q1 2026, buying an estimated $2.58K and bringing the position to 15,255 shares worth $15.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1411.

Two Sigma Securities first reported a position in COCP in Q3 2021 and has held it in 6 quarters since. The position peaked at $26K in Q4 2021. 26 funds tracked by Wall St. Rank hold COCP as of Q1 2026.

Two Sigma Securities held 15,255 shares of Cocrystal Pharma worth $15.4K as of Q1 2026.
Two Sigma Securities bought 2,503 Cocrystal Pharma shares in Q1 2026, an estimated $2.58K.
Cocrystal Pharma made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1411 holding.
Two Sigma Securities first reported a position in Cocrystal Pharma in Q3 2021 and has held it in 6 quarters since.
Two Sigma Securities's Cocrystal Pharma position peaked at $26K in Q4 2021.
26 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.